Abbas Weighs Options in Patient With JAK2-Mutated Polycythemia Vera

[Manouche]

During a Targeted Oncology™ Case-Based Roundtable™ event, Jonathan Abbas, MD, discussed data on therapies for a patient with polycythemia vera who did not adequately respond to hydroxyurea.

targetedonc.com/view/abbas-...

[EPguy]

A good endorsement for Rux in PV. They note that the lower dose (2x 10mg) is less than the 20 used for MF, hence fewer negative events.

[Lena70 in reply to EPguy]

This bums me out. I'm watching and waiting.

[EPguy in reply to Lena70]

Your Dr won't consider Rux or IFN, is that right?

[monarch5000]

10 years ago there were MPN specialists who considered it unethical not to offer ET and PV patients interferon as a first line treatment:

ethical

[Manouche in reply to monarch5000]

He was right. This simple measure could have saved/prolonged the life of many PV sufferers.